Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

NCT02441972 is registered in ClinicalTrials.gov with Wuxi No. 4 People's Hospital as lead sponsor.

NCT NCT02441972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02441972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Lead sponsor
Wuxi No. 4 People's Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2012
Completion date
December 31, 2020
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma, cancer of head and neck, carcinoma, bronchogenic, lymphoma, malignant, soft tissue neoplasms, tumors